1- golestan university, Department of sports sciences, Faculty of Humanitie and social sciences, Golestan University, Gorgan, Iran , y.nazari53@gmail.com 2- saravan university, university of saravan
Abstract: (2 Views)
Background and purpose: Exercise affects the production of reactive oxygen species and inflammatory factors, and medicinal plants play an important role in reducing these indicators. Saffron supplementation has been considered by researchers as a nutritional solution for modulating inflammation and oxidative stress caused by exercise. Therefore, the purpose of this study was to investigate the combined effect of exercise and saffron supplementation on inflammatory and oxidant indices through a systematic review and meta-analysis. Materials and methods: A systematic search of articles published in English and Persian was conducted from the databases Scopus, Science Direct, PubMed, Web of Science, SID, and Magiran until January 2026 and entered into meta-analysis. The standardized mean difference (SMD) and 95% confidence interval (CI) were calculated using a random model. The I2 index was also used to determine the heterogeneity of studies, and publication bias was examined using funnel plot analysis and Egger's test. Results: The results of the present meta-analysis showed that exercise training combined with saffron supplementation significantly reduced tumor necrosis factor-alpha levels (SMD = -1.29, 95% CI =-2.30 to -0.29). However, no significant changes were observed in interleukin-6 levels (SMD = -0.06, 95% CI =-0.91 to -1.03) and malondialdehyde levels (SMD = -0.43, 95% CI =-0.31 to -1.17). Conclusion: Saffron supplementation, along with exercise training, is a very effective strategy for suppressing tumor necrosis factor alpha, a key indicator of systemic inflammation, and prevents the increase in malondialdehyde levels.
Type of Study: Original |
Subject: Special Received: 2026/02/25 | Accepted: 2026/07/12
Send email to the article author
Add your comments about this article
Research code: 1800
Clinical trials code: 0000 مطالعه مرور نظامند و فراتحلیل
Open Access Statement: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium or format, provided that the original work is properly cited.